Unnamed stage
~$8m
Strong Demand Fuels Ceretas IPO, Early ASX Debut Looms
UQ medtech spin-out Ceretas sold its IPO, raising about $8 million, and now targets a fast-tracked ASX debut; the article also recalls ResApp's 2022 acquisition by Pfizer.
Also kalkine.com.au·Dealroom